Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth.

Trousil S, Kaliszczak M, Schug Z, Nguyen QD, Tomasi G, Favicchio R, Brickute D, Fortt R, Twyman FJ, Carroll L, Kalusa A, Navaratnam N, Adejumo T, Carling D, Gottlieb E, Aboagye EO.

Oncotarget. 2016 Jun 14;7(24):37103-37120. doi: 10.18632/oncotarget.9466.

2.

A bioorthogonal (68)Ga-labelling strategy for rapid in vivo imaging.

Evans HL, Nguyen QD, Carroll LS, Kaliszczak M, Twyman FJ, Spivey AC, Aboagye EO.

Chem Commun (Camb). 2014 Aug 28;50(67):9557-60. doi: 10.1039/c4cc03903c.

PMID:
25012592
3.

Radiolabeled RGD tracer kinetics annotates differential αvβ 3 integrin expression linked to cell intrinsic and vessel expression.

Alam IS, Witney TH, Tomasi G, Carroll L, Twyman FJ, Nguyen QD, Aboagye EO.

Mol Imaging Biol. 2014 Aug;16(4):558-66. doi: 10.1007/s11307-013-0710-3. Epub 2013 Dec 6.

PMID:
24310722
4.

Evaluation of deuterated 18F- and 11C-labeled choline analogs for cancer detection by positron emission tomography.

Witney TH, Alam IS, Turton DR, Smith G, Carroll L, Brickute D, Twyman FJ, Nguyen QD, Tomasi G, Awais RO, Aboagye EO.

Clin Cancer Res. 2012 Feb 15;18(4):1063-72. doi: 10.1158/1078-0432.CCR-11-2462. Epub 2012 Jan 10.

Supplemental Content

Loading ...
Support Center